Approval · Notice of Compliance 16875 · 2015
PROGLYCEM: Notice of Compliance 16875
Issued May 1, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16875
- Date
- May 1, 2015
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug product manufacturing site, packaging and testing site. new manufacturing process and a new formulation. other changes include: change in packaging from bottles to blisters, change to drug product shelf life and changes to the drug product specifications
- Therapeutic class
- Hyperglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGLYCEM | Not yet assigned | — |
Medicinal ingredients
- DIAZOXIDE 100 MG per CAP